DFCM
CRBU icon

Dark Forest Capital Management’s Caribou Biosciences CRBU Stock Holding History

Dark Forest Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,274
Closed -$7K – 1184
2022
Q2 		$7K Sell
1,274
-198
-13% -$1.51K ﹤0.01% 578
2022
Q1 		$13K Buy
+1,472
New +$15.5K ﹤0.01% 944

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Dark Forest Capital Management's CRBU Position: Q3 2022 in Review

Dark Forest Capital Management sold out of Caribou Biosciences (CRBU) in Q3 2022, closing a stake of 1,274 shares — an estimated $7K sold.

Dark Forest Capital Management first reported a position in CRBU in Q1 2022 and held it in 2 quarters. The position peaked at $13K in Q1 2022. 113 funds tracked by Wall St. Rank hold CRBU as of Q3 2022.

  • Dark Forest Capital Management reported no remaining Caribou Biosciences position as of Q3 2022 after selling out during the quarter.
  • Dark Forest Capital Management sold 1,274 Caribou Biosciences shares in Q3 2022, an estimated $7K.
  • Dark Forest Capital Management first reported a position in Caribou Biosciences in Q1 2022 and held it in 2 quarters.
  • Dark Forest Capital Management's Caribou Biosciences position peaked at $13K in Q1 2022.
  • 113 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2022.

Based on Dark Forest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.